ChEMBL ligand: CHEMBL240597 (Chenodeoxycholate, NSC-657949, Combidol, Xenbilox, Chenofalk, Chenodeoxycholic Acid, Chenix, Lithofalk, Chenodiol, Chendol 125, Chendol 250, Chenic Acid, Chenocedon)
Bile acid receptor in Mouse [ChEMBL: CHEMBL5343] [UniProtKB: Q60641] There should be some charts here, you may need to enable JavaScript!
Farnesoid X receptor/Bile acid receptor FXR in Human [ChEMBL: CHEMBL2047] [GtoPdb: 603] [UniProtKB: Q96RI1] There should be some charts here, you may need to enable JavaScript!
Retinoid X receptor-α/Bile acid receptor/Retinoic acid receptor RXR-alpha in Mouse [ChEMBL: CHEMBL3885529] [GtoPdb: 610] [UniProtKB: P28700, Q60641] There should be some charts here, you may need to enable JavaScript!
GPBA receptor/G-protein coupled bile acid receptor 1 in Human [ChEMBL: CHEMBL5409] [GtoPdb: 37] [UniProtKB: Q8TDU6] There should be some charts here, you may need to enable JavaScript!
Sodium/bile acid and sulphated solute cotransporter 2/Ileal bile acid transporter in Human [ChEMBL: CHEMBL2778] [GtoPdb: 960] [UniProtKB: Q12908] There should be some charts here, you may need to enable JavaScript!
Plasmodium falciparum 3D7 [ChEMBL: CHEMBL2366922] There should be some charts here, you may need to enable JavaScript!
Vitamin D receptor in Human [ChEMBL: CHEMBL1977] [GtoPdb: 605] [UniProtKB: P11473] There should be some charts here, you may need to enable JavaScript!
FPR1 in Human [GtoPdb: 222] [UniProtKB: P21462] There should be some charts here, you may need to enable JavaScript!

DB	Assay description	Assay Type	Standard value	Standard parameter	Original value	Original units	Original parameter	Reference
Bile acid receptor in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5343] [UniProtKB: Q60641]
ChEMBL	Agonist activity at mouse FXR expressed in HEK293 cells co-expressing mouse RXRalpha and ECRE-luc by luciferase reporter gene assay	F	4.77	pEC50	16800	nM	EC50	Bioorg. Med. Chem. (2011) 19: 7168-7180 [PMID:22018919]
Farnesoid X receptor/Bile acid receptor FXR in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2047] [GtoPdb: 603] [UniProtKB: Q96RI1]
ChEMBL	Activation of human farnesoid X receptor; range is 10-30	B	4.52	pEC50	30000	nM	EC50	J. Med. Chem. (2005) 48: 5383-5403 [PMID:16107136]
ChEMBL	Agonist activity at human recombinant FXR expressed in HEK293 cells coexpressing CMX-GAL4N by luciferase reporter gene assay	F	4.57	pEC50	27000	nM	EC50	Bioorg. Med. Chem. Lett. (2012) 22: 3962-3966 [PMID:22583617]
ChEMBL	Agonistic activity at FXR in HEK293 cells by GAL4 transactivation activity	F	4.57	pEC50	27000	nM	EC50	Bioorg. Med. Chem. (2007) 15: 2587-2600 [PMID:17292610]
ChEMBL	Agonist activity at human GST-fused FXR LBD assessed as coactivator interaction with receptor ligand binding domain by Alphascreen assay	B	4.68	pEC50	21000	nM	EC50	Bioorg. Med. Chem. (2011) 19: 2650-2658 [PMID:21459580]
ChEMBL	Agonist activity at human FXR expressed in human HeLa cells assessed as receptor activation by BSEP promoter-driven firefly luciferase reporter gene assay	B	4.74	pEC50	18000	nM	EC50	J. Med. Chem. (2014) 57: 8035-8055 [PMID:25255039]
ChEMBL	Agonist activity at human full length FXR expressed in HeLa cells cotransfected with pSG5-human RXR after 24 hrs by Dual-Glo luciferase reporter gene assay	B	4.74	pEC50	18000	nM	EC50	Bioorg. Med. Chem. (2015) 23: 3490-3498 [PMID:25934227]
ChEMBL	Agonist activity at farnesoid x receptor(unknown origin)	B	4.74	pEC50	18000	nM	EC50	Bioorg. Med. Chem. (2016) 24: 3232-3245 [PMID:27240466]
ChEMBL	Agonist activity at GST-tagged FXR-LBD (unknown origin) assessed as biotin-labeled SRC-1 recruitment after 30 mins by Alpha Screen assay	B	4.82	pEC50	15000	nM	EC50	Eur J Med Chem (2018) 144: 349-358 [PMID:29275233]
ChEMBL	Agonist activity at human FXR expressed in COS1 cells after 5 hrs by CRE-driven luciferase reporter gene assay	F	4.89	pEC50	13000	nM	EC50	J. Med. Chem. (2007) 50: 4265-4268 [PMID:17685603]
ChEMBL	Agonist activity at GST-tagged FXR-LBD using biotinylated-SRC-1 peptide as substrate preincubated with compound for 30 mins measured after 4 hrs	F	4.89	pEC50	13000	nM	EC50	ACS Med. Chem. Lett. (2012) 3: 273-277 [PMID:24900463]
ChEMBL	Agonist activity at human FXR expressed in COS1 cells by luciferase assay	F	4.89	pEC50	13000	nM	EC50	J. Med. Chem. (2008) 51: 1831-1841 [PMID:18307294]
ChEMBL	Agonist activity at FXR (unknown origin)	B	4.89	pEC50	13000	nM	EC50	Bioorg. Med. Chem. (2016) 24: 3986-3993 [PMID:27372840]
ChEMBL	Agonist activity at FXR expressed in COS1 cells by cell-based bioluminescence assay	F	4.89	pEC50	13000	nM	EC50	J. Med. Chem. (2009) 52: 7958-7961 [PMID:20014870]
ChEMBL	Agonist activity at human recombinant FXR by transactivation of TK-MH100x4-LUC reporter gene in HEK293 cells	F	4.93	pEC50	11700	nM	EC50	Bioorg. Med. Chem. Lett. (2006) 16: 3213-3218 [PMID:16617018]
ChEMBL	Agonist activity at FXR	F	5	pEC50	10000	nM	EC50	Bioorg. Med. Chem. (2011) 19: 6779-6791 [PMID:22014750]
ChEMBL	Agonist activity at FXR (unknown origin) assessed as recruitment of SRC1 peptide to FXR by FRET assay	B	5.05	pEC50	9000	nM	EC50	J Med Chem (2017) 60: 5235-5266 [PMID:28252961]
ChEMBL	Binding affinity for Farnesoid X Receptor (FXR)	B	5.06	pEC50	8660	nM	EC50	Bioorg. Med. Chem. Lett. (2003) 13: 1865-1868 [PMID:12749886]
ChEMBL	Effective concentration against Farnesoid X receptor (FXR)	B	5.06	pEC50	8660	nM	EC50	J. Med. Chem. (2002) 45: 3569-3572 [PMID:12166927]
ChEMBL	Binding affinity for human Farnesoid X receptor in FRET assay	B	5.06	pEC50	8660	nM	EC50	J. Med. Chem. (2004) 47: 4559-4569 [PMID:15317466]
ChEMBL	Binding affinity to FXR assessed as ligand-dependent SRC1 recruitment by FRET based co-activator assay	F	5.06	pEC50	8660	nM	EC50	J. Med. Chem. (2006) 49: 4208-4215 [PMID:16821780]
ChEMBL	Agonist activity at human FXR assessed as recruitment of SRC1 peptide by TR-FRET assay	B	5.06	pEC50	8660	nM	EC50	ACS Med Chem Lett (2017) 8: 1246-1251 [PMID:29259742]
ChEMBL	Transactivation of full-length FXR (unknown origin) expressed in HEK293 cells after 18 hrs by dual-glo luciferase reporter gene assay	B	5.15	pEC50	7010	nM	EC50	MedChemComm (2018) 9: 1630-1638
ChEMBL	Agonist activity at FXR assessed as activation by cell based luciferase transactivation assay	F	5.2	pEC50	6310	nM	EC50	Bioorg. Med. Chem. Lett. (2008) 18: 5497-5502 [PMID:18815030]
GtoPdb	-	-	5.3	pEC50	-	-	-	Science (1999) 284: 1365-8 [PMID:10334993]; Mol. Cell (1999) 3: 543-53 [PMID:10360171]
ChEMBL	Effective concentration for recruitment of SRC-1 LxxLL-containing peptide to human Farnesoid X receptor	B	5.46	pEC50	3500	nM	EC50	J. Med. Chem. (2005) 48: 5383-5403 [PMID:16107136]
ChEMBL	Ligand dependent recruitment of SRC1(676-700) peptide to human Farnesoid X-activated receptor by fluorescence resonance energy transfer assay	B	5.47	pEC50	3400	nM	EC50	J. Med. Chem. (2000) 43: 2971-2974 [PMID:10956205]
Retinoid X receptor-α/Bile acid receptor/Retinoic acid receptor RXR-alpha in Mouse (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL3885529] [GtoPdb: 610] [UniProtKB: P28700, Q60641]
ChEMBL	Agonist activity at full length mouse FXR/RXRalpha expressed in human HEK293 cells assessed as induction of transcriptional activity after 18 hrs by dual luciferase reporter gene assay	F	4.77	pEC50	16800	nM	EC50	Bioorg. Med. Chem. (2011) 19: 6779-6791 [PMID:22014750]
GPBA receptor/G-protein coupled bile acid receptor 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5409] [GtoPdb: 37] [UniProtKB: Q8TDU6]
ChEMBL	Agonist activity at human TGR5 receptor expressed in NCI-H716 cells assessed as intracellular cAMP level by TR-FRET assay	F	4.52	pEC50	30000	nM	EC50	Bioorg. Med. Chem. (2011) 19: 2650-2658 [PMID:21459580]
ChEMBL	Agonist activity at wild type TGR5 (unknown origin)	B	4.99	pEC50	10290	nM	EC50	ACS Med. Chem. Lett. (2013) 4: 1158-1162 [PMID:24900622]
ChEMBL	Agonist activity at human TGR5 expressed in CHO cells after 5 hrs by CRE-driven luciferase reporter gene assay	F	5.17	pEC50	6710	nM	EC50	J. Med. Chem. (2007) 50: 4265-4268 [PMID:17685603]
ChEMBL	Agonist activity at human TGR5 expressed in CHO cells by luciferase assay	F	5.17	pEC50	6710	nM	EC50	J. Med. Chem. (2008) 51: 1831-1841 [PMID:18307294]
ChEMBL	Agonist activity at TGR5 expressed in NCI-H716 cells assessed as cAMP level after 60 mins by FRET analysis	F	5.17	pEC50	6700	nM	EC50	ACS Med. Chem. Lett. (2012) 3: 273-277 [PMID:24900463]
ChEMBL	Agonist activity at human GPBAR1 expressed in HEK293 cells assessed as increase in intracellular cAMP level after 30 mins by cAMP-Glo assay	B	5.21	pEC50	6100	nM	EC50	Bioorg. Med. Chem. (2015) 23: 1613-1628 [PMID:25735208]
GtoPdb	-	-	5.4	pEC50	-	-	-	Biochem. Biophys. Res. Commun. (2002) 298: 714-9 [PMID:12419312]
Sodium/bile acid and sulphated solute cotransporter 2/Ileal bile acid transporter in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2778] [GtoPdb: 960] [UniProtKB: Q12908]
ChEMBL	TP_TRANSPORTER: inhibition of Taurocholate uptake in ASBT-expressing COS cells	F	5.48	pKi	3300	nM	Ki	Am. J. Physiol. (1998) 274: G157-G169 [PMID:9458785]
Plasmodium falciparum 3D7 (target type: ORGANISM) [ChEMBL: CHEMBL2366922]
ChEMBL	Antiplasmodial activity against Plasmodium falciparum 3D7 assessed as reduction in parasite viability by parasite lactate dehydrogenase assay	F	4.72	pIC50	18900	nM	IC50	Eur. J. Med. Chem. (2015) 100: 10-17 [PMID:26063305]
Vitamin D receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1977] [GtoPdb: 605] [UniProtKB: P11473]
ChEMBL	Antagonist activity against VP16 tagged-VDR-LBD (unknown origin) expressed in HEK293T cells assessed as inhibition of 1,25-dihydroxyvitamin D3-induced SRC1 coactivator peptide recruitment after 16 hrs by luciferase reporter gene based two hybrid assay	B	4.3	pIC50	>50000	nM	IC50	Eur. J. Med. Chem. (2016) 109: 238-246 [PMID:26774929]
FPR1 in Human [GtoPdb: 222] [UniProtKB: P21462]
GtoPdb	-	-	4	pKi	-	-	-	Inflamm. Res. (2000) 49: 744-55 [PMID:11211928]

ChEMBL data shown on this page come from version 27:

Gaulton A, Hersey A, Nowotka M, Bento AP, Chambers J, Mendez D, Mutowo P, Atkinson F, Bellis LJ, Cibrián-Uhalte E, Davies M, Dedman N, Karlsson A, Magariños MP, Overington JP, Papadatos G, Smit I, Leach AR. (2017) 'The ChEMBL database in 2017.' Nucleic Acids Res., 45(D1). DOI: 10.1093/nar/gkw1074. [PMCID:5210557]